Vision has a significant impact on physical, emotional as well as the psychological state of human health. Degeneration of photoreceptors in the eye in diseases such as retinitis pigmentosa (RP) gradually hinders visual ability of one million individuals worldwide 1 . More frequently (~15 million worldwide), people have severe loss of vision due to other diseases such as age-related macular degeneration (AMD) when degeneration of photoreceptors of the eye hinders the visual cortex from receiving signals from retinal ganglion cells, thus preventing image information [1] [2] [3] [4] . To date, there is no reliable method to restore lost vision due to these diseases 4 and most of the current clinical treatments are focused on slowing down the progression of the disease 5 . Even with highly-invasive surgical procedures such as retinal implants and transplants 6 , and stem cell therapy 7 , true restoration of vision is far from the horizon due to several challenges. For example, the subretinal implants [8] [9] suffers from the disadvantages of damage to the device over a period of time, and the microphotodiode may not be able to produce sufficient current to stimulate adjacent neurons with the use of ambient light. Similarly, the epiretinal implants [9] [10] lead to cellular proliferation due to surgical implantation of the device causing disordered stimulation patterns resulting from electrical stimulation of both axons and cell bodies of ganglion cells 9 . Besides being highly invasive in nature, all the existing methods for restoration of vision have low spatial resolution, and non-specific cellular activation 5 .
Cellular specificity and mechanical non-invasiveness can be achieved using optogenetic stimulation with high temporal precision by introducing a light-activated molecular channel, such as channelrhodopsin-2 (ChR2), into specific groups of cells by genetic targeting [11] [12] [13] [14] [15] . Since very low intensity (~mW/ mm 2 ) light is necessary for optogenetic stimulation [11] [12] , high-resolution activation of the degenerated retina is feasible using light from external µLED arrays projected to various retinal neuronal layers after photo-sensitization using ChR2. The primary method for delivery of ChR2-encoding genes to specific neuronal layers employs viral transfection which has high transduction efficiency and persistent gene expression 16 . Both non-specific transfection of the retina as well as promoter-specific targeting of retinal ganglion cells of adult mice and rats using viral methods have been successful [17] [18] [19] [20] [21] [22] [23] [24] . However, use of viruses can lead to unexpected inflammatory responses, immunological reactions, and improper gene integration 25 . Further, the viral method limits the size of plasmid that can be packaged and delivered. Unlike adenoviral vectors, which are unable to substantially reinduce transgene expression by reinjection in rodents, electroporation has the ability to do so 26 , providing an important clinical advantage over adenoviral vectors [27] [28] . To avoid the limitations and existing concerns regarding use of viruses, and because the eye is accessible to external delivery methods, we attempted in-vivo electroporation of adult degenerated retina of mice models and monitored expression of ChR2
Stimulation of retinal neurons using optogenetics via use of chanelrhodopsin-2 (ChR2) has opened up a new direction for restoration of vision for treatment of retinitis pigmentosa (RP). Here, we report non-viral in-vivo electroporation of degenerated retina of adult RP-mice with ChR2-plasmids and subsequent in-vivo imaging of retina to confirm expression. Further, we demonstrate that in addition to efficient non-viral delivery of ChR2 to a specific retinal layer, threshold level of stimulation light needs to be delivered onto the retina for achieving successful behavioral outcome. Measurement of intensity of light reaching the retina of RP-mouse models along with geometrical optics simulation of light propagation in the eye is reported in order to determine the stimulating source position for optimal light delivery to the retina. The light-guided navigation of mice with ChR2 expressing retinal ganglion cells was found to be significantly improved over a long distance in correlation with stimulation intensity.
February 2012| 2 genes in the retina, using in-vivo confocal microscopy. In the past, subretinal injection of plasmid DNA combined with electroporation resulted in efficient transgene expression. Further, in the case of ChR2-based treatment of retinitis pigmentosa, it would be highly desirable to reinduce transgene expression by reinjection, and electroporation provides this opportunity.
While optogenetic stimulation of ON-bipolar cells 20, 24 has led to improvement of visual function, recent studies on stimulation of retinal ganglion cells provided contradictory behavioral results 17, 19, [21] [22] [23] . The disparity between the behavioral results could arise due to differences in expression level and/or differences in light intensity reaching the retina. For a successful behavioral outcome, it is imperative to ensure that the threshold level of stimulation light is delivered onto the retina to activate ChR2-sensitized neurons. Here, we report measurements of intensity of light reaching the retina of RP-mouse models along with geometrical optics simulation of light propagation in the eye, in order to determine the stimulating source position for optimal light delivery to the retina. In-vivo imaging of degenerated-retina, sensitized by in-vivo electroporation of adult RP mice, confirmed efficient ChR2 expression. The light-guided navigation of mice with Thy1-ChR2-YFP expressing retinal ganglion cells was found to be significantly improved over a long distance and correlated well with stimulation intensity.
Non-viral transduction and in-vivo monitoring of ChR2-expression
As an alternative to viral-based gene transfer, nonviral vectors are easier to prepare and less prone to cause an immunologic reaction. Electroporation [29] [30] [31] has earlier been evaluated for gene delivery to the retina of adult (8 weeks old) rd1/rd1 mice. The electroporation method can most easily be applied to readily accessible tissues such as the eye. This also removes the technical limitations on size of the construct (that can be inserted into the virus in the case of viral delivery) and therefore promoters of any size can be in inserted into the construct. For transfection by electroporation, only ChR2-plasmids were injected, following which the eye was placed within a hemisphere cathode on the cornea and a hemisphere anode with a groove that slides around the optic nerve on the posterior surface of the eye. Fig. 1a shows the schematic method for electroporation-based delivery of ChR2. The actual electrode for in-vivo transfection of the retina is shown in Fig. 1b . A function generator was used to deliver a variable number of pulses (width: 10 or 50 ms) separated by 100 ms with the voltage set at 10 or 5 V. Lipofection was also carried out to compare the efficiency with that of electroporation. For lipofection experiments, ChR2-plasmids (promoter-ChR2-pEYFP) were suspended in OMEM (Invitrogen) containing 400 µl/ml of Lipofectamine-2000 (Invitrogen). 1 µl of vehicle mixture was injected using a sharpened tip of a sterilized microsyringe inserted through the sclera into the vitreous cavity. In order to quantify the efficiency of the in-vivo electroporation method, as compared to liposome mediated delivery, we monitored the ChR2-expression ( Fig. 1c-e) , one week after electroporation, by upright confocal microscopy (LSM 510, Zeiss) with a 20X longworking distance objective. Number of cells/mm 2 x fluorescence intensity was used as parameter for estimation of efficiency. Confocal imaging was carried out in-vivo to confirm expression before the treated mice were tested for light-activated restoration of vision. Seven days after injection of Thy1-ChR2-YFP in 1 µl of aqueous medium (OMEM), there was no identifiable gene (YFP) expression (data not shown). While use of only lipofectamine led to very low level expression, use of lipofectamine with an electric field did not lead to significant improvement over the case where only the electric field is applied on naked plasmids. In contrast, in all the eyes (n=6) evaluated 7 days after injection of the same amount of plasmid combined with electroporation with a power of 5 V/mm (10 pulses of 50 ms each separated by 100ms), the marker YFP expression was significant (Fig. 1d, e) . For in-vivo imaging, the pupil was dilated using tropicamide. The panels d & e of Fig. 1 show the Z-stack images of the same eye separated by 30 µm along the axial direction. The pupil is marked by the dotted curve.
Our results demonstrate that RGC in the central as well as the peripheral part of the retina is transfected. Fig.  1f shows the comparison of efficiency of transfection by liposome and electric-field-mediated delivery. The high magnification in-vitro epifluorescence imaging of transfected retinal ganglion cells (Fig. 1g) shows efficient expression of ChR2 in both soma and axons. The fluorescent axonal projections can be seen in Fig. 1h . In order to confirm ChR2-YFP expression, immunostaining specific to YFP was carried out. Fig. 1 (i) and (j) shows the XY and XZ-confocal sections of the transfected retina explant, immuno-stained for YFP, with nuclei co-stained with DAPI. As shown in Fig. 1j , the retinal ganglion cells in the specific layer (Thy1 promoter) are found to express ChR2. Thus, retinal cell-specific gene transfer is achievable with no lipid carrier and low-power electroporation.
Simulation and measurement of intensity reaching the retina at varying distances of excitation source
For simulating the light intensity reaching the retina, an in-vitro model of a mouse eye is considered, which is being illuminated by a diverging blue light emerging from an optical fiber (core diameter: 200µm) tip placed at varying distances from the cornea-lens surface. Zemax modeling of the eye was done in the sequential mode. Fig. 2a shows the total power output at the retina of the mouse eye being irradiated at varying distances using a diverging optical fiber source. The peak irradiance reaching the retina as a function of source distance is shown in Fig. 2b. Fig. 2c shows the setup for measurement of light transmitted to the retina. The normalized power measured at varying distances from the source fiber is shown in Fig. 2d . As shown in Fig. 2d , the intensity of light reaching the retina is higher in the presence of focusing optics (cornea and lens) of the eye than in absence of it between the source and receiving fiber.
As shown in Fig. 2a , though the total power reaching the retina decreases at larger distance of the source fiber, the peak irradiance increases (Fig. 2b) . This can be attributed to the fact that though some light is lost at a larger source distance due to the finite size of the collecting eye-optics and the pupil size. The imaging spot size decreases significantly when the source distance is increased from 2mm to 5mm. These two effects counteract leading to the obtained peak irradiance pattern (Fig. 2b) . While peak irradiance is important for generating an action potential, the spot size at the retina will determine spatial resolution. However, the total transmitted-power irradiating individual cells of retina is important for overall stimulation efficiency. Therefore, for the design of a retinal prosthesis or even in evaluating behavioral improvements in experimental settings, these parameters need to be optimized in order to find the desired effect while using optogenetic stimulation. In order to estimate the actual power reaching the retina, power measurements were carried out in the darkadapted mice eye, illuminated with diverging light from an optical fiber (200 µm core) and power measured from the receiving fiber (200µm core) inserted through the back of the eye up to retina via a guiding needle. Fig. 2d shows normalized power measured at the receiver fiber end with varying distances from the source fiber. The presence of the eye in between the source and the receiver fiber led to less decrease in received power as a function of source-distance (Fig. 2d) . This can be attributed to the fact that eye-optics acting as a condenser in collecting the diverging light from the source and focusing back on to the receiving fiber. It can be noted that the decrease in measured power is ~2.5 times when Nature Precedings Article February 2012| 4 the source fiber is moved from 2 to 5 mm, while the theoretical simulations (Fig. 2a) based on physical optics propagation shows a decrease of ~7.5 times for a similar source-receiver distance. This discrepancy can be attributed to the fact that the peak irradiance increased (Fig. 2b) with increasing source distance. And since the receiving fiber has finite core size and acceptance angle, it cannot receive the total power reaching retina and therefore may not exactly match the theoretical simulations (Fig. 2a) .
Effect of improved light sensitivity of the retina on mouse behavior in water maze
To determine restoration of vision, behavioral testing in a water maze task 32 was carried out. It involved determination of the score for the mice swimming towards a stimulating light source before and after electro-optogenetic treatment. To determine restoration of vision in ChR2-transfected mice, one week after injection of plasmids, mice were tested with an open water maze. Every time the mouse was put close to the center of the maze, the platform was changed from the end of one arm to another. After training for one week, the performance of the mouse was recorded. Fig. 3a shows time-lapse sequence of a mouse (transfected with ChR2) moving towards the light source. The platform inside the water maze, acts as a reward system to mice that are constantly swimming since they can rest instead of having to swim. The mice with restored vision (eye treated by electroporation of Thy1-ChR2-YFP) were able to respond to the light emitted from the LED array and were able to reach the platform faster than untreated. Since the LED light is diverging, the intensity of light decreases away from the source (Fig.  3b) . The behavioral improvement of the treated mice was found to depend on the intensity of the activation light with a threshold intensity (or distance) from where the treated mouse could respond to the light (Fig. 3c) . Since the mice are swimming in the water maze, the platform provides a reward to them where they can rest instead of having to swim.
Before electroporation, the rd1/rd1 mice are considered as controls. The mice with restored vision (eye treated by electroporation of Thy1-ChR2-YFP) were able to respond to the light emitted from the LEDs and were able to reach the platform faster than untreated mice. The behavior of the treated mice was found to depend on the intensity of the activation light with a threshold intensity (or distance) from where the treated mouse could respond to the light. Since the LED light is diverging, the intensity of light decreases away from the LED source. The mouse was placed at various distances along the beam path in order to find out the threshold light intensity. The variation of stimulation intensity at different distances from the source (Fig. 3b) correlates well with the mouse swimming score (Fig. 3c) . The score is defined as the percent of mice reaching the platform based on their initial position (when the light was switched on). Both non-specific transfection of the retina as well as promoter-specific targeting of bipolar and retinal ganglion cells of adult mice and rats using viral methods have been established [17] [18] [19] [20] [21] [22] [23] [24] . Though it has been recently reported that ChR2-protein is non-toxic and do not lead to an immune response 24 , significant concerns such as the immune response exist for current viral delivery methods 25, 33 . Further, for a viable ChR2-based human therapy, the expression of ChR2 must be stable, robust, and reinducible. When adenoviral vectors are injected into the eye to transduce retinal cells, the transgene expression peaks within a few days and then declines and is generally undetectable by one month after injection 34 . Unlike adenoviral vectors, which are unable to substantially reinduce transgene expression by reinjection in rodents 34 , electroporation has been able to do so 26 , providing an important advantage over adenoviral vectors. In spite of our current results which show that ChR2-protein expression is stable and remains functional for several months, in the case of ChR2 based treatment, it would be highly desirable to reinduce transgene expression by reinjection, and electroporation provides this opportunity. Low power electroporation without any lipid carrier provided efficient retinal cell-specific gene transfer using optimal electric field parameters (strength, pulse duration, and number of pulses). While in vivo electroporation could deliver ChR2 to retinal cells over the whole retina, it will be highly desirable to optogenetically treat only those areas of the retina that have undergone photodegeneration rather than the whole retina. To achieve this scanning near the IR laser microbeam can be used for delivery of ChR2 to localized areas of the retina 35 . Such uniqueness in spatially-targeted delivery of genes to the peripheral retina will be ideal for restoring lost-vision of RP patients experiencing tunnel vision during aging.
Recent use of light sensitive chloride channel (Halorhodopsin) expression in longer-persisting cone photoreceptors has shown new promise for therapeutic intervention for restoration of vision 36 . Since the proposed electro/optoporation method will not only eliminate the requirement of viral delivery, it will be able to deliver light-sensitive ion-channels (ChR2 and Halorhodopsin) to spatially targeted degenerated retina areas, thus paving the way for translation of the technology to clinical trials. Our success in guiding the optogenetically treated rd1/rd1 mouse over a distance of 100cm was attributed to efficient transfection of retinal ganglion cells, optimal light (intensity) delivery and careful training.
Conclusions
Stimulation of retinal neuronal cells using optogenetics via use of chanelrhodopsin-2 and blue light has opened up a new direction for restoration of vision with respect to the treatment of retinitis pigmentosa. In contrast to earlier viral-method-based delivery of ChR2 onto retinal ganglion cells, we successfully demonstrated in-vivo electroporation of the RP mice eye and improved behavior subsequent to ChR2 transfection. Our simulations and measurement of intensity distribution of light reaching the retina of the RP mouse models showed that optimal divergence and distance of the stimulating source is required for efficient delivery of light to the retina. Further, the spot size at the retina, contributing to the spatial resolution in optogenetically restored vision, was found to depend on the source positioning. The behavioral improvement in mice with ChR2 transfected retina was found to correlate with the stimulation intensity reaching the retina.
Materials and methods

Mouse preparation
Retinal degenerated mice (rd1/rd1 -C57BL/6J-Pde6b rd1-2J ) and C57BL/6 wild type mice (control) were obtained from Jackson laboratory and bred in the animal facilities of the university. Mice were maintained on a 12:12 light cycle (lights on at 07:00). Once the animals were acclimated to the animal facility for ~1 week, they were anesthetized with 90 mg/kg ketamine, 10 mg/kg xylazine and placed in a stereotaxic frame (Kopf Instruments). In all experiments attention was paid to the ethical guidelines for investigations of experimental pain in conscious animals, and the procedures were approved by the IACUC.
Transfection of ChR2-YFP into rd1/rd1 mouse retina Adult (8 weeks old) rd1/rd1 mice were treated humanely in strict compliance with IACUC on the use of animals in research. For transfection of specific layers of retina in-vivo electroporation and lipofection was used. ChR2-plasmids with Thy1 promoter to target retinal ganglion cells, and pEYFP was fused for visualization of expression. For lipofection experiments, ChR2-plasmids (promoter-ChR2-pEYFP) were suspended in OMEM containing 400 µl/ml of Lipofectamine-2000 (Invitrogen). Mixtures of plasmids and lipid-containing media were incubated for 20 minutes at room temperature before injection. Before intra-vitreous injections, mice were anesthetized, pupils were dilated, and a sharpened tip of a sterilized micro-syringe was inserted through the sclera into the vitreous cavity. For electroporation, the injections were carried out with a 32-G needle on a Hamilton microsyringe to deliver 1 µl of plasmids into each eye, following which the eye was placed within a hemispherical cathode on the cornea and a hemispherical anode with a groove that slides around the optic nerve on the posterior surface of the eye. A function generator was used to deliver a variable number of pulses (width: 10 or 50 ms) separated by 100 ms with the voltage set at 10 or 5 V.
Behavioral assessment
The mice were divided into 3 groups. Mice in group 1 (control) were trained in the water maze task for a duration of 7 days and then tracked twice a week for about 4 weeks. Mice in group 2 were injected with ChR2 construct (Thy1-ChR2-pEYFP), followed by electroporation. Mice in group 2 were trained in the water maze task for a period of 7 days prior to transfection. A removable platform with a diameter of 6 cm and height of 8 cm was placed into the pool. The maze was then filled with water to a depth of 7 cm at a temperature of 25°C. A diverging LED array (Rep rate: 10Hz) was directed into center of the maze. The light intensity at different distances was measured with a power meter (PM100D, Thorlabs Inc.). One week after injection of plasmids, mice behavior in water maze task was quantified twice a week at varying distances from the light source. Ethovision software was used to analyze the behavior of mice in the maze. % of mice finding the platform (light source) was scored to evaluate the ability of the mouse to sense the light.
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External light source parameters For the light intensity at the retina to be above the ChR2 stimulation threshold, the light source should have sufficient brightness and optimal divergence so that maximum light can be collected and focused by the cornea-lens on to the retina. Unlike highly-packed pigments in photoreceptors of intact retina which amplifies the signal in cascade, cells expressing ChR2 only on the membrane would require orders of magnitude higher light intensity to elicit action potentials. The required photon flux to achieve this depends on the level of ChR2 expression. Assuming maximum ChR2 expression (2x10 7 for a cell of diameter 10µm and ChR2 ion channel cross-section ~10nm
2 ), Grossman et al. 20 have calculated the lower and upper bound for the generating action potential to be ~ 0.05 mW/mm 2 and 10mW/mm 2 , respectively, for blue light (470 nm). From this threshold, cell irradiance, required for generating the action potential and the transmission characteristics of the eye; one can estimate the required radiance of the external light source. The source size, its position from the cornea and divergence need to be optimized for getting optimal modulation transfer function of the imaging system (eye).
Immunostaining
After extraction of the retina, it was incubated for 30 min in 0.25% Triton X-100 and 1% bovine serum albumin (BSA) for 10 minutes. The retina explant was then washed and mounted on gelatin-coated slides, treated with fluorescent-mounting media, and coverslipped. Primary antibody incubation was performed 1 hr at room temperature in 1% BSA/PBS (goat anti-YFP 1:200, Abgent). Sections were then washed and incubated with secondary antibody (Rabbit anti-goat, FITC 1:500, Invitrogen) for 1 hr at room temperature. Following 10 min incubation with Hoechst (1µg/mL), sections were washed and mounted on microscope slides with mounting media.
